Transarterial chemoembolization of hepatocellular carcinoma in patients with the most common comorbidities or previous oncologic malignancy in remission.

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Transarterial?chemoembolization?of hepatocellular carcinoma in patients with the most common comorbidities or previous?oncologic?malignancy?in remission.
Authors

STRAKA Matej ANDRAŠINA Tomáš HUSTÝ Jakub MATKULČÍK Peter KAZDA Tomáš ROHAN Tomáš

Year of publication 2023
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Purpose: To analyze whether previously diagnosed common comorbidity (diabetes mellitus, myocardial infarction, ischemic stroke, chronic obstructive pulmonary disease (COPD) or prior malignancy in complete remission (CR) are independent risk factors afecting survival of patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolisation (TACE). Conclusion: Patiens with HCC treated with TACE and a history of mentioned comorbidities or other malignant tumor in complete remission have non-inferior survival compared to patients without comorbidities.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.